During the past decade, HIV-NAT conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HIV-NAT" #1 sponsor was "The HIV Netherlands Australia Thailand Research Collaboration" with 26 trials, followed by "Gilead Sciences" with 6 trials sponsored, "Kirby Institute" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Avexa" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HIV-NAT" #1 collaborator was "Chulalongkorn University" with 9 trials as a collaborator, "Ministry of Education, Thailand" with 3 trials as a collaborator, "National Health Security Office, Thailand" with 3 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator and "The Government Pharmaceutical Organization" with 3 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "HIV-NAT" are "HIV Infections" (20 trials), "HIV" (8 trials), "Acquired Immunodeficiency Syndrome" (3 trials), "COVID-19" (3 trials) and "Acquired Immune Deficiency Syndrome (AIDS)" (2 trials). Many other conditions were trialed in "HIV-NAT" in a lesser frequency.

Most popular intervention types in "HIV-NAT" are "Drug" (31 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ritonavir" (4 trials), "ATV" (3 trials), "E/C/F/TAF" (3 trials) and "PF-07321332" (3 trials). Other intervention names were less common.

The vast majority of trials in "HIV-NAT" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "HIV-NAT". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in HIV-NAT, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in HIV-NAT, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

HIV-NAT has several departments that took part in Clinical trials: "HIV-NAT, Thai Red Cross AIDS Research Center and Faculty of Medicine Chulalongkorn University" - 2 trials